Literature DB >> 7512323

Reappraisal of in situ immunophenotypic analysis of psoriasis skin: interaction of activated HLA-DR+ immunocompetent cells and endothelial cells is a major feature of psoriatic lesions.

O J de Boer1, C M van der Loos, F Hamerlinck, J D Bos, P K Das.   

Abstract

Psoriasis is an inflammatory skin disease of unknown aetiology. Many observations indicate that T cells play an important role in the pathogenesis of the disease. Upregulation of MHC class-II molecules on immunocompetent cells, endothelial cells and keratinocytes on lesional psoriatic skin has been regarded as a hallmark of the disease. However, there is some controversy in the literature regarding the cell types expressing class-II molecules and there is limited information about the presence of immune cells other than T cells and antigen presenting cells in the cellular infiltrates of psoriatic skin. We therefore reinvestigated the subject using immunocytochemical single and multiple staining techniques. In agreement with earlier reports, our studies showed that the cellular infiltrates in lesional skin consist largely of HLA-DR+/IL-2R+ T cells, HLA-DR+/CD1a+ Langerhans cells, and HLA-DR+/CD68+ macrophages. We found increased HLA-DR expression mostly on immuno-competent cells and endothelial cells, but no prominent HLA-DR expression on keratinocytes in lesional psoriatic skin. Upregulation of HLA-DR on endothelial cells and in mononuclear infiltrates was also evident in the non-lesional skin of psoriatic patients as compared with normal controls. B cells and natural killer cells were also found in the cellular infiltrates in lesional psoriatic skin. In spite of the presence of a large amount of activated T cells in the epidermis, we found that HLA-DR expression on keratinocytes was not a major feature of psoriatic skin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7512323     DOI: 10.1007/bf00370733

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  40 in total

Review 1.  Oral cyclosporin A in the treatment of psoriasis: an overview of studies performed in The Netherlands.

Authors:  M M Meinardi; M A de Rie; J D Bos
Journal:  Br J Dermatol       Date:  1990-06       Impact factor: 9.302

2.  Immunocompetent cells in psoriasis. In situ immunophenotyping by monoclonal antibodies.

Authors:  J D Bos; H J Hulsebosch; S R Krieg; P M Bakker; R H Cormane
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

3.  Two populations of Ia-like molecules on a human B cell line.

Authors:  L A Lampson; R Levy
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

Review 4.  Immunohistological analysis of human lymphoma: correlation of histological and immunological categories.

Authors:  H Stein; K Lennert; A C Feller; D Y Mason
Journal:  Adv Cancer Res       Date:  1984       Impact factor: 6.242

5.  Localization and retention of mycobacterial antigen in lymph nodes of leprosy patients.

Authors:  U Barros; U Ladiwala; T J Birdi; N H Antia
Journal:  Br J Exp Pathol       Date:  1987-10

6.  Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes.

Authors:  R M Grossman; J Krueger; D Yourish; A Granelli-Piperno; D P Murphy; L T May; T S Kupper; P B Sehgal; A B Gottlieb
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

7.  Cyclosporin A: preliminary results in the treatment of psoriasis.

Authors:  C Bonifati; R Clerico; C M Potenza; M Carlesimo
Journal:  Acta Derm Venereol Suppl (Stockh)       Date:  1989

8.  Distribution of CD1a-positive cells in psoriatic skin during the evolution of the lesions.

Authors:  T Bieber; O Braun-Falco
Journal:  Acta Derm Venereol       Date:  1989       Impact factor: 4.437

9.  Human spleen contains phenotypic subsets of macrophages and dendritic cells that occupy discrete microanatomic locations.

Authors:  P J Buckley; M R Smith; M F Braverman; S A Dickson
Journal:  Am J Pathol       Date:  1987-09       Impact factor: 4.307

10.  Characterization of skin-infiltrating lymphocytes in patients with psoriasis.

Authors:  A Nikaein; C Phillips; S C Gilbert; D Savino; A Silverman; M J Stone; A Menter
Journal:  J Invest Dermatol       Date:  1991-01       Impact factor: 8.551

View more
  7 in total

1.  Immuno-inflammatory cell dynamics during cutaneous wound healing.

Authors:  A D Agaiby; M Dyson
Journal:  J Anat       Date:  1999-11       Impact factor: 2.610

2.  Inhibition of T cell cAMP formation by cyclosporin A and FK506.

Authors:  H M Ockenfels; S N Wagner; P Oeljeklaus; B Schneck; G Nussbaum; K H Jakobs; M Goos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-04       Impact factor: 3.000

Review 3.  Therapeutic implications of autoimmune vitiligo T cells.

Authors:  Kepa Oyarbide-Valencia; Jasper G van den Boorn; Cecele J Denman; Mingli Li; Jeremy M Carlson; Claudia Hernandez; Michael I Nishimura; Pranab K Das; Rosalie M Luiten; I Caroline Le Poole
Journal:  Autoimmun Rev       Date:  2006-05-06       Impact factor: 9.754

Review 4.  Psoriasis, T cells and autoimmunity.

Authors:  C E Griffiths; J J Voorhees
Journal:  J R Soc Med       Date:  1996-06       Impact factor: 18.000

5.  Characterization of psoriasiform and alopecic skin lesions in HLA-B27 transgenic rats.

Authors:  H Yanagisawa; J A Richardson; J D Taurog; R E Hammer
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

6.  Linkage analysis of human leukocyte antigen (HLA) markers in familial psoriasis: strong disequilibrium effects provide evidence for a major determinant in the HLA-B/-C region.

Authors:  S Jenisch; T Henseler; R P Nair; S W Guo; E Westphal; P Stuart; M Krönke; J J Voorhees; E Christophers; J T Elder
Journal:  Am J Hum Genet       Date:  1998-07       Impact factor: 11.025

7.  Single-cell RNA sequencing of psoriatic skin identifies pathogenic Tc17 cell subsets and reveals distinctions between CD8+ T cells in autoimmunity and cancer.

Authors:  Jared Liu; Hsin-Wen Chang; Zhi-Ming Huang; Mio Nakamura; Sahil Sekhon; Richard Ahn; Priscila Munoz-Sandoval; Shrishti Bhattarai; Kristen M Beck; Isabelle M Sanchez; Eric Yang; Mariela Pauli; Sarah T Arron; Wai-Ping Fung-Leung; Ernesto Munoz; Xuejun Liu; Tina Bhutani; Jeffrey North; Anne M Fourie; Michael D Rosenblum; Wilson Liao
Journal:  J Allergy Clin Immunol       Date:  2020-12-09       Impact factor: 14.290

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.